Galectin Therapeutics Inc (NASDAQ:GALT)

3.48
Delayed Data
As of Feb 26
 -0.10 / -2.79%
Today’s Change
3.00
Today|||52-Week Range
19.11
+0.29%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization12.0K9.0K9.0K12.0K
 
 
 
 
 
 
Operating ExpensesGross Income-12.0K-9.0K-9.0K-12.0K
 
 
 
 
 
General Expenses4.9M10.4M9.9M12.1M
 
 
 
 
 
Research And Development1.1M3.6M4.5M5.7M
 
 
 
 
 
Total Operating Expenses4.9M10.4M9.9M12.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.9M-10.4M-9.9M-12.1M
 
 
 
 
 
Extraordinary Credit0.000.00200.0K0.00
 
 
Extraordinary Charge-1.2M-524.0K0.000.00
 
 
 
Other Expenses489.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.6M-10.9M-9.7M-12.1M
 
 
 
 
 
Preferred Dividend-3.1M-1.8M-976.0K-867.0K
 
 
 
 
 
Net Income-5.6M-10.9M-9.9M-21.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.4M12.0M15.1M16.9M
 
 
 
 
 
Shares To Calculate EPS Diluted9.4M12.0M15.1M16.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.90-$6.36-$0.72-$1.30
 
 
 
 
 
EPS Diluted-$0.90-$1.08-$0.72-$1.30
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account